Lobbying Activity Report

204-24145

Organization: AstraZeneca Canada Inc.
Associated registration: 8188-204-27
Lobbying Activity date: 2023-02-13
Arranged a meeting: Yes
Posted date: 2023-03-15

In-house lobbyists who participated in the lobbying activity: Ilias Iliopoulos
Jo-Ann Stuart-Chatterley
Gurvinder Kenth
Senior Public Office Holders who were lobbied in this activity: Nathan Michaels, Director of Precision Medicine and Genetic Services
PharmaCare, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Discussions with BC government officials/organizations and elected representative to obtains public reimbursement of AstraZeneca Canada (AZC) innovative treatments for BC Citizens that require access to these treatments, including health system resilience policy and environmental considerations in health care. These discussions will take place with BC government bodies as Pharmacare, the BC Cancer Agency and First Nations Health Authority. This will include discussions on how best to conclude Product Listing Agreement and health care delivery discussions with each of these public entities.
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health
 
Lobbying Activity Report amended on: 2023-03-10 previous entry: 204-24051
Reason for amendment: Needing to include other AZ representatives
 
Senior officer who filed this Lobbying Activity Report: Kiersten Combs
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Date Modified: